The TGA’s medicinal cannabis products review: what stakeholders said and what comes next
19 March 2026
The Therapeutic Goods Administration (TGA) has released its response to the feedback it received to its consultation on the safety and regulatory oversight of unapproved medicinal cannabis products.
Read on
